Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies

L Degenhardt, B Clark, G Macpherson… - The Lancet …, 2023‏ - thelancet.com
Background Opioid dependence is associated with substantial health and social burdens,
and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for …

Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review

GA Angarita, N Emadi, S Hodges… - Addiction science & clinical …, 2016‏ - Springer
Sleep abnormalities are associated with acute and chronic use of addictive substances.
Although sleep complaints associated with use and abstinence from addictive substances …

Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials

J Klimas, MA Hamilton, L Gorfinkel, A Adam… - Systematic reviews, 2021‏ - Springer
Background Although oral opioid agonist therapies (OATs), buprenorphine and methadone,
are effective first-line treatments, OAT remains largely underutilized due to low retention …

Quality of life among opiate-dependent individuals: A review of the literature

J De Maeyer, W Vanderplasschen… - International journal of drug …, 2010‏ - Elsevier
Quality of life (QoL) has become an important outcome indicator in health care evaluation. A
clear distinction has to be made between QoL–focussing on individuals' subjective …

[HTML][HTML] Buprenorphine in the United States: Motives for abuse, misuse, and diversion

HD Chilcoat, HR Amick, MR Sherwood… - Journal of substance …, 2019‏ - Elsevier
Opioid use disorder (OUD) and its consequences are a major public health concern. The
partial agonist buprenorphine is a safe and effective treatment for OUD, but concerns about …

Duration of medication treatment for opioid‐use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study

M Burns, L Tang, CCH Chang, JY Kim, K Ahrens… - …, 2022‏ - Wiley Online Library
Background and aims Medication for opioid use disorder (MOUD) reduces harms
associated with opioid use disorder (OUD), including risk of overdose. Understanding how …

Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives

KL Venner, DM Donovan, ANC Campbell, DC Wendt… - Addictive …, 2018‏ - Elsevier
The US is experiencing an alarming opioid epidemic, and although American Indians and
Alaska Natives (AI/ANs) are especially hard hit, there is a paucity of opioid-related treatment …

Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income …

JP Feelemyer, DC Des Jarlais, K Arasteh… - Drug and alcohol …, 2014‏ - Elsevier
Background Opioid substitution treatment (OST) can increase quality of life (WHOQOL-
BREF) and reduce addiction severity index (ASI) scores among participants over time. OST …

Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatment

J De Maeyer, W Vanderplasschen, J Lammertyn… - Quality of life …, 2011‏ - Springer
Purpose This study explores the current QoL of opiate-dependent individuals who started
outpatient methadone treatment at least 5 years ago and assesses the influence of …

Pharmacotherapy in the treatment of addiction: methadone

MJ Kreek, L Borg, E Ducat… - Women, Children, and …, 2014‏ - api.taylorfrancis.com
them vulnerable to social ostracism, vilification, and prosecution. Fourth, the association of
female sexuality and drug use has been persistent. Last, addicted women have largely …